Shares of vaccine maker Moderna Inc. fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product revenue guidance in six months. Moderna shares fell 2% in ...

Moderna, Inc. (NASDAQ ... Overall, MRNA ranks 5th on our list of Goldman Sachs' top growth investors. While we acknowledge the potential of MRNA as an investment, our conviction lies in the ...

The S&P 500 gained 0.6% on Monday, March 31, boosted by an afternoon rally even as investors brace for the planned onset of reciprocal tariffs later this week.

Goldman Sachs Group Inc.’s executive pay proposal won majority support from shareholders despite criticism the bonuses were ...

Adamczyk joined Goldman Sachs in 2024 as advisory chairman of private investments and operations following a 16-year stint at ...